Show simple item record

dc.contributor.authorOkaecwe, Thokozile
dc.contributor.authorSwanepoel, Abraham J.
dc.contributor.authorPetzer, Anél
dc.contributor.authorBergh, Jacobus J.
dc.contributor.authorPetzer, Jacobus P.
dc.contributor.authorOkaecwe, Thokozile
dc.contributor.authorSwanepoel, Abraham J.
dc.contributor.authorPetzer, Anél
dc.contributor.authorBergh, Jacobus J.
dc.contributor.authorPetzer, Jacobus P.
dc.date.accessioned2014-01-08T13:16:38Z
dc.date.available2014-01-08T13:16:38Z
dc.date.issued2012
dc.identifier.citationOkaecwe, T. et al. 2012. Inhibition of monoamine oxidase by 8-phenoxymethylcaffeine derivatives. Bioorganic & medicinal chemistry, 20(14):4336-4347. [https://doi.org/10.1016/j.bmc.2012.05.048]en_US
dc.identifier.issn0968-0896
dc.identifier.issn1464-3391(Online)
dc.identifier.urihttp://hdl.handle.net/10394/9888
dc.identifier.urihttps://doi.org/10.1016/j.bmc.2012.05.048
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0968089612004221
dc.description.abstractA recent study has reported that a series of 8-benzyloxycaffeines are potent and reversible inhibitors of both human monoamine oxidase (MAO) isoforms, MAO-A and -B. In an attempt to discover additional caffeine derivatives with potent MAO inhibitory activities, and to contribute to the known structure–activity relationships of MAO inhibition by caffeine derived compounds, the present study investigates the MAO inhibitory potencies of series of 8-phenoxymethylcaffeine and 8-[(phenylsulfanyl)methyl]caffeine derivatives. The results document that the 8-phenoxymethylcaffeine derivatives act as potent reversible inhibitors of MAO-B, with IC50 values ranging from 0.148 to 5.78 μM. In contrast, the 8-[(phenylsulfanyl)methyl]caffeine derivatives were found to be weak inhibitors of MAO-B, with IC50 values ranging from 4.05 to 124 μM. Neither the 8-phenoxymethylcaffeine nor the 8-[(phenylsulfanyl)methyl]caffeine derivatives exhibited high binding affinities for MAO-A. While less potent than the 8-benzyloxycaffeines as MAO-B inhibitors, this study concludes that 8-phenoxymethylcaffeines may act as useful leads for the design of MAO-B selective inhibitors. Such compounds may find application in the therapy of neurodegenerative disorders such as Parkinson’s disease. Using molecular docking experiments, this study also proposes possible binding orientations of selected caffeine derivatives in the active sites of MAO-A and -B.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectMonoamine oxidaseen_US
dc.subjectReversible inhibitionen_US
dc.subjectCompetitiveen_US
dc.subjectSelectivityen_US
dc.subjectCaffeineen_US
dc.subjectPhenoxymethylcaffeineen_US
dc.subject8-[(Phenylsulfanyl)methyl]caffeineen_US
dc.subjectMolecular dockingen_US
dc.titleInhibition of monoamine oxidase by 8-phenoxymethylcaffeine derivativesen_US
dc.typeArticleen_US
dc.contributor.researchID20965389 - Okaecwe, Thokozile Audrey Dorcas
dc.contributor.researchID12264954 - Petzer, Anél
dc.contributor.researchID10727388 - Petzer, Jacobus Petrus
dc.contributor.researchID10057072 - Bergh, Jacobus Johannes
dc.contributor.researchID13029207 - Swanepoel, Abraham Johannes


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record